Recombinant Litoria rothii Rothein 4.1
Description
Biological Context and Related Peptides
Rothein peptides are part of Litoria rothii’s seasonal defense secretions. In winter, these frogs predominantly produce Rothein 1 and caerulein 1.2, which interact with CCK-B receptors (CCK2R) to modulate smooth muscle contraction and lymphocyte proliferation . While Rothein 4.1’s specific activity remains uncharacterized, its structural similarity to other rotheins suggests potential roles in:
-
Receptor Binding: Hydrophobic residues (e.g., Trp, Phe) may facilitate CCK2R interactions .
-
Immune Modulation: Analogs like Rothein 1 exhibit lymphocyte-stimulating properties .
Production Methodology
-
Cloning: Genetic sequences are inserted into baculoviral vectors for insect cell expression, ensuring high-yield production .
-
Purification: Affinity chromatography and RP-HPLC achieve >85% purity .
Table 2: Key Synthesis Parameters
| Parameter | Details |
|---|---|
| Expression Region | Amino acids 1–22 |
| Tagging | Cytoplasmic domain tag (type unspecified) |
| Stability | 12-month shelf life (lyophilized) |
Comparative Analysis with Other Rotheins
Rothein 4.1 differs from related peptides in sequence and seasonal expression:
Table 3: Rothein Family Comparison
Research Implications
-
Therapeutic Potential: CCK receptor-targeting peptides are explored for gastrointestinal disorders and cancer .
-
Seasonal Peptide Dynamics: L. rothii’s winter secretion shift highlights ecological adaptation strategies .
Limitations and Future Directions
-
Functional Data Gap: No direct studies on Rothein 4.1’s pharmacological activity exist.
-
Structural Studies: NMR or X-ray crystallography could elucidate binding motifs.
